NY A02163

Prohibits insurers and health care plans from allowing or requiring insurer-designated pharmacies to dispense medications directly to patients for transport to physician offices, hospitals, or clinics for administration.

Prevents insurers from requiring home infusion pharmacies or external infusion sites for sterile intravenous drugs ordered by physicians to patients in their homes.

Requires insurers establishing agreements with providers for insurer-designated pharmacy medication distribution to include 90 days' notice, same-day delivery, 24/7 pharmacist access, cold chain logistics, medication pedigree documentation, FDA compliance expertise, national accreditation, ready-to-administer dosage forms, and site-neutral payment covering provider intake, storage, and disposal costs.

Prohibits insurers from requiring medications needing sterile compounding by providers or patient-specific dosages based on same-day lab or test results to be distributed from insurer-designated pharmacies to provider locations.

Applies requirements to health insurance companies, health maintenance organizations, and health care plans under New York insurance and public health law.